you are here: Home News Biocon Biologics

Biocon Biologics

Biocon Biologics names Deepali Naair as Global Head, Brand & Corp Comm
Biocon Biologics' success in biosimilars points to the future pathway for Indian pharma
Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA
Biocon Biologics secures USFDA approval for biosimilar product to treat ophthalmology conditions
Biocon stock falls 4% after subsidiary sells branded formulations biz to Eris Lifesciences
Eris Lifesciences’ insatiable appetite for growth is driving up its debt
Biocon Biologics signs 10-year supply deal with Eris Lifesciences for Rs 1242 crore
Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada
Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in Australia
Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan
Biocon Biologics completes integration of Viatris' biosimilar business in 120 countries
Eris Lifesciences to buy Biocon arm’s derma, nephro units; Eris, Biocon shares in focus
Eris acquires nephrology, dermatology brands of Biocon for Rs 366 crore
Biocon may list biosimilars business by 2025 first half - CEO
Biocon gets 8 observations from USFDA after inspection of Malaysia insulins facility
Biocon gains as arm takes over commercialization of biosimilars business
Biocon Biologics takes over Viatris' biosimilar business in over 70 countries
Biocon Biologics biosimilar to treat certain inflammatory diseases now available in US
Diabetes and cardiovascular diseases account for over 33% of Jan Aushadhi medicine sales, reveals govt data
Biocon Biologics elevates Shreehas Tambe as MD & CEO
Biocon Biologics completes acquisition of Viatris' global biosimilars business
Biocon Biologics inks out-licensing agreement with Yoshindo Inc
Biocon, Yoshindo partner to commercialise 2 biosimilar assets in Japan
Bribery case: CBI court rejects bail plea of Jt Drugs Controller, Biocon Biologics official, three others
CBI court to pronounce order in CDSCO bribery case today

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Biocon Biologics

Biocon Biologics names Deepali Naair as Global Head, Brand & Corp Comm

Biocon Biologics' success in biosimilars points to the future pathway for Indian pharma

Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA

Biocon Biologics secures USFDA approval for biosimilar product to treat ophthalmology conditions

Biocon stock falls 4% after subsidiary sells branded formulations biz to Eris Lifesciences

Eris Lifesciences’ insatiable appetite for growth is driving up its debt

Biocon Biologics signs 10-year supply deal with Eris Lifesciences for Rs 1242 crore

Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada

Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in Australia

Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan

Biocon Biologics completes integration of Viatris' biosimilar business in 120 countries

Eris Lifesciences to buy Biocon arm’s derma, nephro units; Eris, Biocon shares in focus

Eris acquires nephrology, dermatology brands of Biocon for Rs 366 crore

Biocon may list biosimilars business by 2025 first half - CEO

Biocon gets 8 observations from USFDA after inspection of Malaysia insulins facility

Biocon gains as arm takes over commercialization of biosimilars business

Biocon Biologics takes over Viatris' biosimilar business in over 70 countries

Biocon Biologics biosimilar to treat certain inflammatory diseases now available in US

Diabetes and cardiovascular diseases account for over 33% of Jan Aushadhi medicine sales, reveals govt data

Biocon Biologics elevates Shreehas Tambe as MD & CEO

Biocon Biologics completes acquisition of Viatris' global biosimilars business

Biocon Biologics inks out-licensing agreement with Yoshindo Inc

Biocon, Yoshindo partner to commercialise 2 biosimilar assets in Japan

Bribery case: CBI court rejects bail plea of Jt Drugs Controller, Biocon Biologics official, three others

CBI court to pronounce order in CDSCO bribery case today